The Enterprise Value as of September 2024 (TTM) for Resverlogix Corp. (RVXCF) is 20.51M

According to Resverlogix Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.51M. This represents a change of -8.32% compared to the average of 22.37M of the last 4 quarters.

Resverlogix Corp. (RVXCF) Historical Enterprise Value (quarterly & annually)

How has RVXCF Enterprise Value performed in the past?

The mean historical Enterprise Value of Resverlogix Corp. over the last ten years is 187.17M. The current 20.51M Enterprise Value has changed 995.68% with respect to the historical average. Over the past ten years (40 quarters), RVXCF's Enterprise Value was at its highest in in the October 2018 quarter at 477.65M. The Enterprise Value was at its lowest in in the April 2018 quarter at 587.00K.

Resverlogix Corp. (RVXCF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Resverlogix Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Resverlogix Corp. (RVXCF) Average Enterprise Value

How has RVXCF Enterprise Value performed in the past?

The current Enterprise Value of Resverlogix Corp. (RVXCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Resverlogix Corp. (RVXCF) Enterprise Value vs. Peers

How is RVXCF’s Enterprise Value compared to its peers?

Resverlogix Corp.’s Enterprise Value is less than Cellectis S.A. (144.28M), greater than Biotron Limited (14.38M), less than Small Pharma Inc. (38.25M), less than Covalon Technologies Ltd. (71.57M), greater than Bioasis Technologies Inc. (395.84K), less than Fennec Pharmaceuticals Inc. (132.54M), less than Biohaven Pharmaceutical Holding Company Ltd. (3.66B), less than ImmunityBio, Inc. (3.32B), greater than Cadrenal Therapeutics, Inc. Common Stock (7.79M), less than Foghorn Therapeutics Inc. (438.10M), greater than Comera Life Sciences Holdings, Inc. (-913895.00), less than Coya Therapeutics, Inc. (0), less than NewAmsterdam Pharma Company N.V. (58.14M), less than Centessa Pharmaceuticals plc (938.49M), less than Eliem Therapeutics, Inc. (1.85B), less than Inhibrx, Inc. (334.23M), less than Merrimack Pharmaceuticals, Inc. (26.90M), greater than Celcuity Inc. (-10189682.00), less than Enliven Therapeutics, Inc. (630.02M), less than null (990.64M),

Build a custom stock screener for Resverlogix Corp. (RVXCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Resverlogix Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Resverlogix Corp. (RVXCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Resverlogix Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.